2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO43] Mini-Oral Session 43　Gastrointestinal Cancer 5（Miscellaneous）
【E】

Sat. Feb 19, 2022 3:50 PM - 4:40 PM Room 12 (Prince Hall 2, B2F, The Prince Kyoto Takaragaike)

Chair：Yasushi Tsuji（Department of Medical Oncology, Tonan Hospital），Ichinosuke Hyodo（Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center）

[MO43-6] Safety and efficacy of anti-PD-1 antibody dostarlimab in patients with mismatch repair-deficient (dMMR) solid cancers

○Thierry Andre1, Dominique Berton2, Giuseppe Curigliano3, Susan L Ellard4, Jose Manuel Trigo Perez5, Hendrik-Tobias Arkenau6, Cyril Abdeddaim7, Wei Guo8, Ellie Im9, Naureen Starling10 (1.Sorbonne University and Saint-Antoine Hospital, 2.GINECO & Institut de Cancerologie de l'Ouest, Centre René Gauducheau, 3.Division of Early Drug Development for Innovative Therapies, IEO, European Institute of Oncology IRCCS, and University of Milano, 4.BC Cancer-Kelowna, 5.Medical Oncology Department, Hospital Ramón y Cajal, 6.Sarah Cannon Research Institute UK Limited, 7.Centre de Lutte Contre le Cancer-Centre Oscar Lambret, 8.START Madrid-FJD, Fundación Jiménez Diaz Hospital, 9.GlaxoSmithKline (GSK), 10.Royal Marsden Hospital NHS Foundation Trust)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password